References
- Hennig-Pauka I, Bremerich S, Nienhoff H, Schröder C, Verspohl J, Strutzberg-Minder K et al. (2007). Respiratory disease markers in porcine bronchoalveolar lavage fluid. J Vet Med A Physiol Pathol Clin Med, 54:434–440.
- Holko I, Urbanova J, Holkova T, Kmet V. (2004). Diagnosis of main bacterial agents of porcine respiratory diseases complex (PRDC) using PCR detection of Mycoplasma hyopneumoniae. Vet Med, 49:35–41.
- Hornish RE, Kotarski SF. (2002). Cephalosporins in veterinary medicine - ceftiofur use in food animals. Curr Top Med Chem, 2:717–731.
- Frye JG, Fedorka-Cray PJ. (2007). Prevalence, distribution and characterisation of ceftiofur resistance in Salmonella enterica isolated from animals in the USA from 1999 to 2003. Int J Antimicrob Agents, 30:134–142.
- Sustronck B, Deprez P, van Loon G, Coghe J, Muylle E. (1997). Efficacy of the combination sodium ceftiofur-flumethasone in the treatment of experimental Pasteurella haemolytica bronchopneumonia in calves. Zentralbl Veterinarmed A, 44:179–187.
- Chu X, Song K, Xu K, Zhang X, Zhang X, Song Y et al. (2010). Ceftiofur attenuates lipopolysaccharide-induced acute lung injury. Int Immunopharmacol, 10:600–604.
- Ci X, Song Y, Zeng F, Zhang X, Li H, Wang X et al. (2008). Ceftiofur impairs pro-inflammatory cytokine secretion through the inhibition of the activation of NF-κB and MAPK. Biochem Biophys Res Commun, 372:73–77.
- Lu B. (1998). Microencapsules and microencapsulation. In: Lu B, ed. New Technology and New Dosage Forms of Drugs. Beijing: Peoples’ Medical Publishing House, pp. 165–252.
- Tabata Y, Ikada Y. (1989). Synthesis of gelatin microspheres containing interferon. Pharm Res, 6:422–427.
- Lu et al. (2003). Lung-targeting microspheres of carboplatin. Int J Pharm, 265:1–11.
- Li M, Liu X, Liu X. (2009). Comparison of characteristics between glutaraldehyde- and genipin-crosslinked gelatin microspheres. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 23:87–91.